Radiopharm Theranostics Limited

CHIA:RAD Stock Report

Market Cap: AU$65.2m

Radiopharm Theranostics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Riccardo Canevari

Chief executive officer

AU$3.2m

Total compensation

CEO salary percentage25.9%
CEO tenure3yrs
CEO ownership0.6%
Management average tenure2.9yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Riccardo Canevari's remuneration changed compared to Radiopharm Theranostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-AU$48m

Mar 31 2024n/an/a

-AU$47m

Dec 31 2023n/an/a

-AU$47m

Sep 30 2023n/an/a

-AU$41m

Jun 30 2023AU$3mAU$825k

-AU$35m

Mar 31 2023n/an/a

-AU$30m

Dec 31 2022n/an/a

-AU$26m

Sep 30 2022n/an/a

-AU$28m

Jun 30 2022AU$3mAU$631k

-AU$30m

Compensation vs Market: Riccardo's total compensation ($USD2.19M) is above average for companies of similar size in the Australian market ($USD310.93K).

Compensation vs Earnings: Riccardo's compensation has been consistent with company performance over the past year.


CEO

Riccardo Canevari

3yrs

Tenure

AU$3,180,964

Compensation

Mr. Riccardo Canevari is Managing Director & Chief Executive Officer since September 13, 2021 and Director at Radiopharm Theranostics Limited. He was Chief Commercial Officer of Advanced Accelerator Applic...


Leadership Team

NamePositionTenureCompensationOwnership
Paul Hopper
Founder & Executive Chairman3.6yrsAU$459.97k6.87%
A$ 4.5m
Riccardo Canevari
MD, CEO & Director3yrsAU$3.18m0.62%
A$ 402.1k
Vittorio Puppo
Chief Operating Officer2.3yrsAU$1.29mno data
Thomas Tulip
Chief Business Officerno dataAU$504.74k0.046%
A$ 30.0k
Phillip Hains
CFO, Company Secretary & Directorno dataAU$88.39k0.73%
A$ 478.7k
Nathan Jong
Company Secretary2.9yrsno datano data

2.9yrs

Average Tenure

Experienced Management: RAD's management team is considered experienced (2.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Paul Hopper
Founder & Executive Chairman3.6yrsAU$459.97k6.87%
A$ 4.5m
Riccardo Canevari
MD, CEO & Directorno dataAU$3.18m0.62%
A$ 402.1k
Phillip Hains
CFO, Company Secretary & Directorless than a yearAU$88.39k0.73%
A$ 478.7k
Eric Aboagye
Member of Scientific Advisory Boardno datano datano data
Ian Turner
Non-Executive Director3.4yrsAU$537.00k0.21%
A$ 138.6k
Leila Alland
Non-Executive Director2.3yrsAU$101.40k0.049%
A$ 32.2k
Sara A. Hurvitz
Member of Scientific Advisory Boardno datano datano data
Hoi Hong
Member of Scientific Advisory Boardno datano datano data
Johannes Notni
Member of Scientific Advisory Boardno datano datano data
David Ulmert
Member of Scientific Advisory Boardno datano datano data
Hester Larkin
Non-Executive Director2.6yrsAU$65.00k0.030%
A$ 19.3k
Susann Brady-Kalnay
Member of Scientific Advisory Board2.3yrsno datano data

2.4yrs

Average Tenure

Experienced Board: RAD's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.